- Home
- MDGL vs DLB Comparison
MDGL vs DLB Comparison
Compare MDGL & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- DLB
- Stock Information
- Founded
- MDGL 2011
- DLB 1965
- Country
- MDGL United States
- DLB United States
- Employees
- MDGL N/A
- DLB N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- DLB Multi-Sector Companies
- Sector
- MDGL Health Care
- DLB Miscellaneous
- Exchange
- MDGL Nasdaq
- DLB Nasdaq
- Market Cap
- MDGL 7.5B
- DLB 7.9B
- IPO Year
- MDGL N/A
- DLB 2005
- Fundamental
- Price
- MDGL $323.98
- DLB $80.63
- Analyst Decision
- MDGL Buy
- DLB Strong Buy
- Analyst Count
- MDGL 10
- DLB 4
- Target Price
- MDGL $354.75
- DLB $99.50
- AVG Volume (30 Days)
- MDGL 317.3K
- DLB 515.8K
- Earning Date
- MDGL 05-06-2025
- DLB 05-01-2025
- Dividend Yield
- MDGL N/A
- DLB 1.64%
- EPS Growth
- MDGL N/A
- DLB 40.49
- EPS
- MDGL N/A
- DLB 2.70
- Revenue
- MDGL $180,133,000.00
- DLB $1,315,146,000.00
- Revenue This Year
- MDGL $228.41
- DLB $7.56
- Revenue Next Year
- MDGL $73.44
- DLB $5.47
- P/E Ratio
- MDGL N/A
- DLB $29.87
- Revenue Growth
- MDGL N/A
- DLB 2.71
- 52 Week Low
- MDGL $189.00
- DLB $66.35
- 52 Week High
- MDGL $377.46
- DLB $89.66
- Technical
- Relative Strength Index (RSI)
- MDGL 45.41
- DLB 44.92
- Support Level
- MDGL $310.00
- DLB $78.74
- Resistance Level
- MDGL $350.50
- DLB $82.63
- Average True Range (ATR)
- MDGL 13.02
- DLB 1.45
- MACD
- MDGL -1.72
- DLB -0.15
- Stochastic Oscillator
- MDGL 34.52
- DLB 41.91
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.